TY - JOUR T1 - Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg JF - Anticancer Research JO - Anticancer Res SP - 3423 LP - 3427 DO - 10.21873/anticanres.14327 VL - 40 IS - 6 AU - REINHARD E. FRIEDRICH AU - CHRISTIAN HAGEL AU - FELIX K. KOHLRUSCH AU - INA SCHANZE AU - ILSE WIELAND AU - MARTIN ZENKER Y1 - 2020/06/01 UR - http://ar.iiarjournals.org/content/40/6/3423.abstract N2 - Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant hereditary disease with complete penetrance and a very variable phenotype. Recent research has shown that postzygotic NF1 gene mutations occur to a far greater extent than previously thought. The phenotype of affected individuals reflects the time of somatic mutation and the phenotype is correspondingly diverse. This report describes histological and genetic findings in a case of mosaic NF1, the clinical control of which documents almost stationary skin findings over a period of 9 years. Case Report: The 55-year-old female first presented for advice on a strip of nodular skin tumours of the calf skin. She had no hallmarks of NF1. It was only 9 years later that she had the skin tumours removed, all of which were partially diffuse and partially plexiform neurofibroma. The genetic examination showed an atypical large deletion of the NF1 gene in the skin tumours, but not in overlying skin or blood. Conclusion: Segmental NF1 is a distinct type of mosaic/somatic NF1 mutation. The phenotype of diffuse and plexiform skin neurofibromas can resemble cutaneous neurofibroma. Surgical therapy for segmental neurofibromatosis does not differ from the concepts for treating nerve sheath tumours in NF1 patients with a germline NF1 mutation. ER -